Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 1:27 AM
NCT ID:
NCT05145894
Eligibility Criteria:
Inclusion Criteria:
For COPD patients:
* Patients able and willing to sign an informed consent to participate in the study;
* Patient is aged 40 years or older with a smoking history of ≥10 pack years;
* Patients with COPD confirmed previously by a detailed medical history and examination;
* Patients presenting with moderate or severe exacerbation of chronic obstructive pulmonary disease.
* Patient is treated by a monotherapy long-acting muscarinic antagonist (LAMA), or LAMA plus long acting beta2-agonist (LABA), or inhaled corticosteroid (ICS) plus LABA, or LAMA plus LABA plus ICS.
For asthma patients:
* Patients able and willing to sign an informed consent to participate in the study;
* Patient is aged 3 years or older;
* Patients with asthma confirmed previously by a detailed medical history and examination;
* Patients presenting with moderate or severe exacerbation of asthma;
* Patient is treated by a monotherapy ICS or ICS plus LABA or other controllers.
Exclusion Criteria:
* Age up to 3 years for asthma patients and up to 40 years for COPD patients;
* Patient refusal to participate in the study;
* Patients with subcutaneous emphysema, with damaged skin on the surface of the chest, with drainage in the pleural space, patients undergoing mechanical ventilation;
* Patients with asthma-COPD overlap or presence of other known chronic lung conditions such tuberculosis, cystic fibrosis or clinically significant bronchiectasis;
* Mental illness, other known acute diseases or known chronic decompensated diseases, such as a known active malignancy or severe heart failure, other known ongoing infection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Study:
NCT05145894
Study Brief:
Protocol Section:
NCT05145894